Chemosensitizing activity of caffeic acid in multidrug-resistant MCF-7/Dox human breast carcinoma cells

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 1913-1917

  Ahn, Chang Ho ^a   Choi, Won Chul ^a,b   Kong, Jay Yang ^a,c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Pusan National University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Breast cancer; Caffeir acid; Chemosensitizing; Multidrug resistance

Indexed keywords

CAFFEIC ACID; DOXORUBICIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BREAST CARCINOMA; CELL STRAIN MCF 7; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CAFFEIC ACIDS; CARBON RADIOISOTOPES; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; KINETICS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030796173     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Biedler JL: Drug resistance: genotype and phenotype. Cancer Res 54: 666-678, 1994.
2. Hayes JD and Wolf CR: Molecular mechanisms of drug resistance. Biochem J 272: 281-295, 1990.
3. Fairchild CR, Ivy SP, Kao-Shan C, Whang-Peng J, Rosen M, Israel MA, Melera PW, Cowan KH and Goldsmith ME: Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47: 5141-5148, 1987.
4. Batist G, Tulpule A, Sinha BK, Katkis AG, Myers CE and Cowan KH: Overexpression of a novel anionic glutathione transferease in multidrug-resistant human breast cancer cells. J Biol Chem 261: 15544-15549, 1986.
5. Ahn C-H and Kim JK: Characterization of protein kinase C in doxorubicin-sensitive and resistant human breast MCF-7 cancer cell lines. J Biomed Res 1: 52-58, 1991.
6. Fine RL, Patel J and Chabner BA: Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 85: 582-586, 1988.
7. Fine RL, Ozol R, Patel J and Ahn C-H: Phosphoprotein, protein kinase C and second messenger system changes in human multidrug resistant cancer cells. In: Drug Resistance in Cancer Therapy (Ozol F ed), New York, Kluwer Academic, 1989, pp107-123.
8. Gottesman M and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
9. Ford JM: Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological considerations. Eur J Cancer 32A: 991-1001, 1996.
10. Fisher GA, Lum BL, Hausdorff J and Sikic BI: Pharmacological considerations in the modulation of multidrug resistance. Eur J Cancer 324: 1082-1088, 1996.
11. Kramer RA, Zakher J and Kim G: Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science 241: 694-697, 1988.
12. Kelly J, Engqvist-Goldstein A, Montali JA Wheatley J B, Schmidt DE and Kauvar L: Variability of glutathione S-transferase isoenzyme,patterns in matched normal and cancer human breast tissue. Biochem J 304: 843-848, 1994.
13. Dusre L, Mimnaugh GG, Myers CE and Sinha BK: Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Res 49: 511-515, 1989.
14. Ploemen JH, van Ommen B, de Haan A, Schefferlie JG, and van Bladeren PJ: In vitro and in vivo reversible and irreversible inhibition of rat glutathione S-transferase isoenzymes by caffeic acid and its 2-S-glutathionyl conjugate. Food Chem Toxicol 31: 475-482, 1993
15. Senjo M and Ishibashi T: Possible involvement of glutathione S-transferases in the cell growth of C6 astroglioma cells. J Neurochem 50: 163-166, 1988.
16. Ahn C-H, Kong JK, Choi WC and Hwang MS: Selective inhibition of the effects of phorbol ester on doxorubicin resistance and P-glycoprotein by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) in multidrug-resistant MCF-7/Dox human breast carcinoma cells. Biochem Pharmacol 52: 393-399, 1996.
17. Lawrence DA: Identification and activation of latent transforming growth factor β. Meth Enzymol 198: 327-336, 1991.
18. Arrick BA, Kore M and Derynck R: Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res 50: 299-303, 1990
19. Qian XD and Beck WT: Progesterone photoaffinity labels. P-glycoprotein in multidrug resistant human leukemic lymphoblasts. J Biol Chem 265: 18753-18756, 1990.
20. Hwang MS, Ahn C-H, Pine PS, Yin JJ, Hrycyna CA, Licht T and Aszalos A: Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells. Int J Cancer 65: 389-397, 1996.
21. Fan D, Fidler IJ, Ward NE, Seid C, Earnest LE, Housey GM and O'Brien CA: Stable expression of a cDNA encoding rat brain protein kinase CβI confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 12: 661-667, 1992.
22. Schisselbauer JC, Crescimanno M, D'Alessandro N, Clapper M, Toulmond S, Tapiero H and Tew KD: Glutathione, glutathione S-transferases, and related redox enzymes in adriamycinresistant cell lines with a multidrug resistant phenotype. Cancer Comm 1: 133-139, 1989.
23. Sammuels BL, Murray JL, Cohen MB, Safa AR, Sinha BK, Townsend AJ, Beckett MA and Weichselbaum RR: Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res 51: 521-527, 1991.
24. Zugmaier F, Ennis BW, Deschauer B, Katz D, Knabbe C, Wilding G, Daly P, Lippman ME and Dickson RB: Transforming growth factor type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol 141: 353-361, 1989.
25. Takaishi K, Kawata S, Ito N, Tamura S, Shirai Y and Tarui S: Effects of phorbol ester on cell growth inhibition by transforming growth factor β1 in human hepatoma cell lines. Biochem. Biophys Res Comm 171: 91-96, 1990.
26. Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ and Longo DL: Growth inhibition of a human lymphoma cell lines: induction of a transforming growth factor β-mediated autocrine loop by a phorbol myristate acetate. Cell Growth Diff 1: 549-557, 1990.
27. Ewen M, Sluss H, Whitehouse L and Livingston D: Cdk4 modulation by TGF-β leads to cell cycle arrest. Cell 74: 1009-1029, 1993.
28. Koff A, Ohtsuki M, Polyak K, Roberts J and Massague J: Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependcnt by kinase by TGF-β. Science 260: 536-539, 1993.
29. Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, Ichiyoshi Y and Sugimachi K: Transforming growth factor-beta 1 induces apoptosis in gastric cancer cells through a p53-independent pathway. Cancer 77(8 Suppl): 1628-1633, 1996.
30. Chaouchi N, Arvanitakis L Auffredou MT, Blanchard DA, Vazquez A and Sharma S: Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11: 1615-1622, 1995.
31. Havrilesky LJ, Hurteau JA, Whitaker RS, Elbendary A, Wu S, Rodriguez GC, Bast RC Jr. and Berchuck A: Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Cancer Res 55: 944-948, 1995.